Cipher Pharmaceuticals Inc.
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (5)
Compared with Healthcare companies in Canada.
P/E ratio
8.6Investors pay 8.6 for every 1 of Cipher Pharmaceuticals Inc.'s yearly profit, lower than 79% of Healthcare companies in Canada.
P/B ratio
1.73The share price is 1.73 times Cipher Pharmaceuticals Inc.'s book value per share, lower than 62% of Healthcare companies in Canada.
Market cap
C$333 MThe total market value of all of Cipher Pharmaceuticals Inc.'s shares at today's price (share price × number of shares), larger than 85% of Healthcare companies in Canada. PosiCap size class: Mini Cap.
Return on equity (ROE)
23.5%Cipher Pharmaceuticals Inc. earned 23.5% on its shareholders' money over the last year, higher than 90% of Healthcare companies in Canada.
Dividend yield
NoneCipher Pharmaceuticals Inc. does not currently pay a dividend.
Questions
What is Cipher Pharmaceuticals Inc.'s P/E ratio?
Investors pay 8.6 for every 1 of Cipher Pharmaceuticals Inc.'s yearly profit, lower than 79% of Healthcare companies in Canada.
What is Cipher Pharmaceuticals Inc.'s return on equity?
Cipher Pharmaceuticals Inc. earned 23.5% on its shareholders' money over the last year, higher than 90% of Healthcare companies in Canada.
Does Cipher Pharmaceuticals Inc. pay a dividend?
No. Cipher Pharmaceuticals Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.